ENDRA Life Sciences(NDRA) - 2025 Q2 - Quarterly Results

FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 9, 2025 ENDRA Life Sciences Inc. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 | Delaware | 001-37969 | 26-0579295 | | --- | --- | --- | | (State or other jurisdiction | (Commission | (IRS Employer | | of incorporation) | File Number) | Identification No.) | | 3600 Green Court, Suite ...